The stock market is currently undergoing a thematic shift, one that favors weight loss drug manufacturers such as Eli Lilly and Company (LLY) over fitness-related names such as Peloton (PTON). Akin to a stone rolling down a hill, gathering momentum with each turn, such shifts represent generational wealth-making opportunities on the back of accelerating trends, as was witnessed when Netflix ushered in the age of content streaming or when Tesla popularized EVs as a crucial ingredient in combatting climate change. Eli Lilly and Company (LLY) Vs. Peloton (PTON) Eli Lilly and Company's Mounjaro injections treat type-2 diabetes as well as […]
Read full article at https://wccftech.com/wall-street-is-downgrading-fitness-stocks-such-as-peloton-and-mooning-over-glp-1-drug-makers-such-as-eli-lilly-and-company-lly/
WccftechContinue reading/original-link]